CHICAGO, IL— Tumor biology-based therapy offers excellent outcomes among children with intermediate risk (IR) neuroblastoma (NB), according to results from a prospective phase 3 reduction of therapy study from the Children’s Oncology Group.
Recommendations provided for management of advanced disease without and with brain metastases.
ANAHEIM, CALIFORNIA—For patients with recurrent glioblastoma, carboplatin-based intra-arterial chemotherapy is relatively safe and well-tolerated, with quality of life being maintained or improved during treatment.
Patients with glioblastoma have very few treatment options to prolong survival; however, a new vaccine may change that.
Great strides have been made in cancer research this year, including targeted therapies that may soon be used as a standard of care.
Hippocampal avoidance whole brain radiotherapy (HA-WBRT) is associated with less memory decline at four months.
Glioblastoma typically has low survival rates, but targeted therapies and surgery may offer hope for some patients.
Gliomas are the most common form of brain tumors, which begin in the glial (supportive) tissue. Different types of gliomas include astrocytomas, brain stem gliomas, ependymomas, and oligodendrogliomas.1 Based on the World Health Organization Grading System, grade I lesions generally have low proliferative potential with the possibility of a cure after surgical resection. Grade II…
Among patients with newly-diagnosed glioblastoma, adding bevacizumab to standard first-line chemoradiotherapy does not improve survival, found data presented at ASCO 2013.
In peritumoral cerebral edema, corticorelin acetate improves steroid-induced myopathy.
